Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial.
- DOI
- 10.1016/s0090-4295(96)90059-x
- Published
- 1996 Jul
- Container
- Urology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0090-4295-96-90059-x,
title = {Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial.},
author = {Sarosdy MF and Lowe BA and Schellhammer PF and Lamm DL and Graham SD Jr and Grossman HB and See WA and Peabody JO and Moon TD and Flanigan RC and Crawford ED and Morganroth J},
year = {1996},
journal = {Urology},
doi = {10.1016/s0090-4295(96)90059-x},
url = {https://doi.org/10.1016/s0090-4295(96)90059-x}
}RIS
TY - JOUR TI - Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial. AU - Sarosdy MF AU - Lowe BA AU - Schellhammer PF AU - Lamm DL AU - Graham SD Jr AU - Grossman HB AU - See WA AU - Peabody JO AU - Moon TD AU - Flanigan RC AU - Crawford ED AU - Morganroth J PY - 1996 JO - Urology DO - 10.1016/s0090-4295(96)90059-x UR - https://doi.org/10.1016/s0090-4295(96)90059-x ER -
APA
MF, S., BA, L., PF, S., DL, L., Jr, G. S., HB, G., WA, S., JO, P., TD, M., RC, F., ED, C., & J, M. (1996). Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial.. Urology. https://doi.org/10.1016/s0090-4295(96)90059-x
Source records
- pubmed · retrieved 2026-09-26T18:53:57.492Z